North American Vaccine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine

NVX 1.495

-4.8%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: andy harrison who wrote (350)	4/7/1998 12:49:00 PM
From: Don W Stone	Read Replies (1) of 507

Spoke to the Company: STATUS RE FDA APPROVAL, ESSENTAILLY THE SAME. We are on: " OR SHORTLY THEREAFTER". That to me says literally anytime soon. We will also be seeing the approval for DTaP-IPV for Germany and Austria shortly ( in the next couple of months). There may be a third European country also. The Chiron buyout of Chiron Behring has no effect on the NVX/Behring agreement. We just mite be hearing more about some of their other vaccine activity in the next few months. In summary, Things are going very well "fundamentally" for NVX. This is why you don't see the Institutions participating in this little selloff today or any downturns of recent. Today the lasrgest block so far was for 1400 shares all the rest are a few 100's etc. It is very trying but it is wo rth hanging in there . The Company is as upbeat as they have ever been. :-} It is really a BUYING opportunity.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next